Histogen Email - Funding Problems!

[UK_]

Hi Guys,

A friend of mine contacted Histogen a few days ago regarding an update for HSC, he asked questions related to the possibility of a Phase III trial in humans, how we as consumers could contribute to the success of HSC and also when it would likely be released to the public.

Unfortunately Histogen seem to be lagging due to funding issues, please see the email reply from CEO Gail Naughton herself and let me know what you think.

Hi,

The attached is the poster form of the presentation that was recently given at the International Investigative Dermatology meeting in Edinburgh.

The results are strong. We need to perform a large animal chronic toxicity test to support a Phase III trial with a total number of 100-150 injections.

I truly appreciate your offer to make HSC a success. The only factor that has slowed progress is lack of sufficient research funds to move forward quickly.

Any suggestions on that topic would be greatly appreciated.

Thanks and take care,

Gail

Gail has confirmed once again the strength of the findings, I feel the Phase IIb trial will be the animal toxicity tests and then a final Phase III trial will be conducted before it is released.